Seek Labs Unveils SeekIt
Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient. SALT LAKE CITY–(BUSINESS WIRE)–#SeekLabs–Seek... Read more.
Mentor Capital Gains 390% During Move to Uranium, Coal, Oil and Gas
Exxon, Chevron, Occidental, Arch, and Cameco are First in Energy Index PLANO, Texas–(BUSINESS WIRE)–$MNTR #Covid–Mentor Capital, Inc. (OTCQB: MNTR)... Read more.
BILL Responds to Market Rumor
SAN JOSE, Calif.–(BUSINESS WIRE)–BILL (NYSE: BILL), a leader in financial automation software for small and midsize businesses (SMBs), today responded... Read more.
AMRA Medical at AASLD The Liver Meeting® Showcases MRI-Based Technology and Muscle Biomarkers linked to liver disease severity and progression
LINKÖPING, Sweden–(BUSINESS WIRE)–#AMRAMedical—AMRA Medical has a large presence at this year’s The Liver Meeting®. A total of nine abstracts... Read more.
ROKiT Racing Star Deagen Fairclough Set to Race With Hitech in 2024 ROKiT British F4 Championship
SILVERSTONE, England–(BUSINESS WIRE)–Deagen Fairclough has been unveiled as the first confirmed entry with Hitech Grand Prix for the 2024 ROKiT F4 British... Read more.
More people are reading Microsoft Viva Engage but online conversations are slipping – SWOOP Analytics report
NEW YORK–(BUSINESS WIRE)–#InternalComms–The world’s largest analysis of Microsoft Viva Engage has found more people than ever are using the enterprise... Read more.
Free App from Taqtile for Digitizing Work Instructions Adds Media Library to Centralize and Organize Knowledge Content
Manifest Maker, Recognized by Fast Company as a 2023 “World Changing Idea,” Increases Utility and Usability SEATTLE–(BUSINESS WIRE)–Taqtile, Inc.,... Read more.
Ed Freedman’s Stable Road Foundation Announces $1 Million Donation to GEM for Maui Fire Relief
MAUI, Hawaii–(BUSINESS WIRE)–Ed Freedman’s Stable Road Foundation has announced a $1 million donation to Global Empowerment Mission (GEM), an award-winning... Read more.
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Application based on results from TRANSCEND CLL 004, the first pivotal multicenter trial to show clinical benefit with a CAR T cell therapy in heavily pre-treated... Read more.
KBRA Assigns Preliminary Ratings to Tricon Residential 2023-SFR2
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to four classes of Tricon Residential 2023-SFR2 (TCN 2023-SFR2) single-family rental... Read more.